Raj R Makkar MD

Interventional Cardiology

Vice President, Cardiovascular Innovation and Intervention; Associate Director of the Smidt Heart Institute for Interventional Technologies; Executive Director of Cardiac Interventional Services; Director of Interventional Cardiology Division; Director of the Interventional Cardiology Research Program

Join to view full profile

8700 Beverly BlvdWest Hollywood, CA 90048
Phone+1 310-423-3977
Fax+1 310-423-0106

Dr. Makkar is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Makkar's full profile Already have an account?

Education & Training

Cedars-Sinai Medical CenterFellowship, Interventional Cardiology, 1996 - 1997
Cedars-Sinai Medical CenterFellowship, Cardiovascular Disease, 1993 - 1996
Wayne State University School of MedicineResidency, Internal Medicine, 1990 - 1993
KM School of PG Medicine and ResearchResidency, 1987 - 1990
Gujurat UniversityMB, BS, 1981 - 1987

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 1993 - 2029
MI State Medical License 1993 - 1994
National Board of Physicians and Surgeons Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2015-2016
CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2015-2016
CMS Meaningful Use Stage 1 Certification Sunquest Laboratory, Sunquest Information Systems, Inc., 2015-2016

Clinical Trials

Heart Disease of the Small Arteries in Women and Men
RECRUITING
NA
Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction
COMPLETED
PHASE1
Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration Start of enrollment: 2012 Nov 13
TERMINATED
PHASE1, PHASE2

Publications & Presentations

PubMed

1 citations
Health Status Outcomes 7 Years After Transcatheter or Surgical Aortic Valve Replacement in Low-Surgical Risk Patients With Aortic Stenosis.
Michael I Brener, David J Cohen, Susheel K Kodali, Rebecca T Hahn, Vinod H Thourani
Journal of the American College of Cardiology. 2026-10-06
Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device-Associated Pure Aortic Regurgitation.
Hristian Hinkov, Sara Yousefzada, Isabell A Just, Christoph Klein, Evgenij Potapov
Artificial Organs. 2026-10-01
Benign emergence of pathological Q waves following minimally invasive direct coronary artery bypass surgery: a case series.
Hailei Liu, Laura DiChiacchio, Michael Shehata, Ashkan Ehdaie, Tarun Chakravarty
Journal of Surgical Case Reports. 2026-10-01

Journal Articles

One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve
Brian Whisenant, Samir R Kapadia, Mackram F Eleid, James M Mccabe, Amar Krishnaswamy, Richard W Smalling, Charanjit S Rihal, Raj R Makkar, JAMA Cardiology
Original Investigation Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial
Eugene H Blackstone, Vinod H Thourani, Howard C Herrmann, David J Cohen, Michael J Mack, Raj R Makkar, Samir R Kapadia, Susheel K Kodali, Lars G Svensson, Molly Szerli..., ScienceDirect
Clinical Research Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and Its Imp...
Raj Makkar, MD, ScienceDirect

Lectures

Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural Outcomes
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
Prevention and Management of Bioprosthetic Valve Thrombosis
CRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019

Authored Content

Impact of Pulmonary Artery Dilatation on Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve ReplacementNovember 2021
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020
One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart ValveJuly 2020

Press Mentions

Cardiologists Highlight Early Success with Leaflet Modification Device for Valve-In-Valve TAVRJuly 2nd, 2026
Cover Story | Tricuspid Valve Intervention: Clinical Decision-Making for Patient SelectionJune 1st, 2026
What Heart-Valve Patients Need to Know Before TreatmentApril 25th, 2026